IQVIA Holdings Inc
NYSE:IQV

Watchlist Manager
IQVIA Holdings Inc Logo
IQVIA Holdings Inc
NYSE:IQV
Watchlist
Price: 199.41 USD 0.15%
Market Cap: 36.2B USD
Have any thoughts about
IQVIA Holdings Inc?
Write Note

Gross Margin
IQVIA Holdings Inc

35.2%
Current
35%
Average
44%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
35.2%
=
Gross Profit
5.4B
/
Revenue
15.3B

Gross Margin Across Competitors

Country US
Market Cap 35.9B USD
Gross Margin
35%
Country US
Market Cap 1.2T USD
Gross Margin
55%
Country US
Market Cap 200.4B USD
Gross Margin
41%
Country US
Market Cap 165.4B USD
Gross Margin
60%
Country KR
Market Cap 66.8T KRW
Gross Margin
49%
Country CH
Market Cap 38.4B CHF
Gross Margin
29%
Country US
Market Cap 38.5B USD
Gross Margin
55%
Country US
Market Cap 26.8B USD
Gross Margin
59%
Country US
Market Cap 24.1B USD
Gross Margin
35%
Country CN
Market Cap 164.4B CNY
Gross Margin
40%
Country US
Market Cap 22.1B USD
Gross Margin
60%
No Stocks Found

IQVIA Holdings Inc
Glance View

Market Cap
36.2B USD
Industry
Life Sciences Tools & Services
Economic Moat
None

In the world of healthcare, IQVIA Holdings Inc. emerges as a formidable player, seamlessly blending data analytics with the imperative of human well-being. Born from the merger of IMS Health and Quintiles in 2016, IQVIA stands at the intersection of technology and life sciences, leveraging vast amounts of health-related data to facilitate more informed decisions in drug development and patient care. The company's vast repository consists of a complex tapestry of dynamic insights from around the globe, which it transforms using sophisticated analytical tools. This technical prowess enables IQVIA to offer solutions that span clinical trials, health information services, and advanced analytics, creating substantial value for pharmaceutical and life sciences companies. At the heart of IQVIA’s revenue model lies its ability to provide strategic services that reduce the time and cost associated with the development of new pharmaceuticals. By offering an integrated suite of services from the initial phases of drug research to post-market monitoring, IQVIA assists its clients in navigating regulatory landscapes and commercializing their products effectively. Its expansive technological infrastructure does not just aid in drug development but also enhances patient engagement, creating digital pathways for more personalized healthcare solutions. Thus, IQVIA earns its keep by not only selling information but also by offering transformative insights that sharpen the competitive edge for its clients in the ever-evolving healthcare sector.

IQV Intrinsic Value
267.12 USD
Undervaluation 25%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
35.2%
=
Gross Profit
5.4B
/
Revenue
15.3B
What is the Gross Margin of IQVIA Holdings Inc?

Based on IQVIA Holdings Inc's most recent financial statements, the company has Gross Margin of 35.2%.